Skip to main content

Table 2 Complete blood count and PT and aPTT of the healthy volunteers and patient groups

From: Validation of a modified thromboelastometry approach to detect changes in fibrinolytic activity

 

Healthy volunteers

Sepsis

CTS-TXA

Cirrhotic liver disease

Pregnancy

Hb

(mmol/L)

9.0

(8.4–9.6)

6.0*

(5.6–6.3)

6.2*

(5.7–6.7)

7.7*

(7.2–8.4)

7.8*

(7.0–8.4)

Ht

(L/L)

0.43

(0.40–0.45)

0.29*

(0.27–0.31)

0.29*

(0.26–0.32)

0.38*

(0.34–0.39)

0.36*

(0.34–0.39)

PLT

(x109/L)

178

(139–212)

141

(95–213)

101*

(91–140)

99*

(62–136)

202

(127–234)

WBC

(x109/L)

6.4

(5.4–7.9)

20.1*

(11.5–25.3)

10.7*

(8.3–12.4)

5.0

(4.0–7.5)

10.7*

(9.3–11.7)

PT

(s)

10.5

(10.2–10.8)

11.5*

(10.7–12.1)

11.8*

(11.5–12.4)

13.3*

(13.0–13.5)

9.6*

(9.3–9.6)

aPTT

(s)

27

(26–27)

33.5*

(30–42.5)

30*

(28–33)

29*

(29–34)

25*

(23–25)

  1. Results are median (IQR); * p < 0.05 in comparison to healthy volunteers
  2. Hb Hemoglobin, Ht Hmatocrit, PLT Platelet count, WBC White blood cell count, PT Prothrombin time, aPTT Activated partial thromboplastin time IQR, Interquartile ranges, CTS-TXA, Cardiothoracic surgery patients using tranexamic acid